Yearly Archives: 2023

Community pharmacy contractors (including head office staff) and community pharmacists are invited to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The [...]

The post Share your views on the Pharmacy Quality Scheme appeared first on PSNC Website.

PSNC, working with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback about EPS Paperless, Outcomes and Trackability. Please complete the short EPS survey here We would appreciate views from community pharmacy teams,  including those working within multiple group head offices, who are requested to complete [...]

The post Chance to share your views – EPS outcomes and trackability survey appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml (SSP053). SSP053 was due to expire on 15 December 2023 but the end date has been further extended to Friday 12 January 2024. The Department of Health and Social Care (DHSC) has provided an [...]

The post SSP053 for Clarithromycin 125mg/5ml oral suspension further extended appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. MSN/2023/044 Tier 2 – medium impact Date of issue 6th April 2023 Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023 Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c [...]

The post Medicine Supply Notification: Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estriol (Imvaggis®) 0.03mg pessary. MSN/2023/041 Tier 2 – medium impact Date of issue 6th April 2023 Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023 Alternative estriol vaginal products remain available, as does estradiol 10mcg vaginal tablets, and [...]

The post Medicine Supply Notification: Estriol (Imvaggis® ) 0.03mg pessary appeared first on PSNC Website.